JPM26: Paying cash for obesity drugs, renewed IPO optimism and pharmaβs cell therapy view
unknown
π
Published: 2026-01-14 14:59
π° Source: Yahoo
π Words: 25
π Article Content
Drugmaker CEOs see sales online channels as a budding opportunity, while some biotech investors told BioPharma Dive to expect a rebound in new stock offerings.
π Summary
Drugmaker CEOs see sales online channels as a budding opportunity, while some biotech investors told BioPharma Dive to expect a rebound in new stock offerings.
Scraping Metadata:
Scraped At:
Unknown
Created At:
2026-01-15 00:39:12
Updated At:
2026-01-15 00:39:12
Scraping Job ID:
N/A
Stock Mentions:
EW - [PLACEHOLDER] EW
Relevance: N/A